Urotensin II in Invertebrates: From Structure to Function in Aplysia californica

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Romanova, Elena V ^a   Sasaki, Kosei ^b   Alexeeva, Vera ^b   Vilim, Ferdinand S ^b   Jing, Jian ^b   Richmond, Timothy A ^a   Weiss, Klaudiusz R ^b   Sweedler, Jonathan V ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE PRECURSOR; MESSENGER RNA; UROTENSIN II;

ANIMAL CELL; APLYSIA; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN MAPPING; CONTROLLED STUDY; FEEDING BEHAVIOR; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RNA SEQUENCE; SATIETY; SENSORY NERVE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; APLYSIA; BASE SEQUENCE; CENTRAL NERVOUS SYSTEM; CHEMICAL FRACTIONATION; ELECTROPHYSIOLOGY; FEEDING BEHAVIOR; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; SATIETY RESPONSE; SEQUENCE ANALYSIS, PROTEIN; TANDEM MASS SPECTROMETRY; UROTENSINS;

APLYSIA; APLYSIA CALIFORNICA; INVERTEBRATA; METAZOA; VERTEBRATA;

EID: 84869028783     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048764     Document Type: Article

References (105)

1. Douglas SA, Ohlstein EH, (2000) Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med 10: 229-237.
2. Watanabe T, Arita S, Shiraishi Y, Suguro T, Sakai T, et al. (2009) Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases. Curr Med Chem 16: 550-563.
3. Bern HA, Lederis K (1969) A reference preparation for the study of active substances in the caudal neurosecretory system of teleosts. J Endocrinol 45: Suppl:xi-xii.
4. Pearson D, Shively JE, Clark BR, Geschwind, II, Barkley M, et al. (1980) Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci U S A 77: 5021-5024.
5. Vaudry H, Do Rego JC, Le Mevel JC, Chatenet D, Tostivint H, et al. (2010) Urotensin II, from fish to human. Ann N Y Acad Sci 1200: 53-66.
6. Conlon JM, O'Harte F, Smith DD, Tonon MC, Vaudry H, (1992) Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. Biochem Biophys Res Commun 188: 578-583.
7. Coulouarn Y, Jégou S, Tostivint H, Vaudry H, Lihrmann I, (1999) Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457: 28-32.
8. Coulouarn Y, Fernex C, Jegou S, Henderson CE, Vaudry H, et al. (2001) Specific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord. Mech Dev 101: 187-190.
9. Elshourbagy NA, Douglas SA, Shabon U, Harrison S, Duddy G, et al. (2002) Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br J Pharmacol 136: 9-22.
10. Mori M, Sugo T, Abe M, Shimomura Y, Kurihara M, et al. (1999) Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun 265: 123-129.
11. Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, et al. (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci U S A 95: 15803-15808.
12. Le Roith D, Shiloach J, Roth J (1984) Do recent evolutionary studies provide a rational interpretation? In: Chan-Palay V, Palay SL, editors. Coexistence of Neuroactive Substanses in Neurons. New York: John Wiley and Sons. 411-421.
13. Collins JJ 3rd, Hou X, Romanova EV, Lambrus BG, Miller CM, et al (2010) Genome-wide analyses reveal a role for peptide hormones in planarian germline development. PLoS Biol 8: e1000509.
14. Hummon AB, Richmond TA, Verleyen P, Baggerman G, Huybrechts J, et al. (2006) From the genome to the proteome: uncovering peptides in the Apis brain. Science 314: 647-649.
15. Husson SJ, Landuyt B, Nys T, Baggerman G, Boonen K, et al. (2009) Comparative peptidomics of Caenorhabditis elegans versus C. briggsae by LC-MALDI-TOF MS. Peptides 30: 449-457.
16. Nassel DR, Winther AM, (2010) Drosophila neuropeptides in regulation of physiology and behavior. Prog Neurobiol 92: 42-104.
17. Christie A, Stemmler E, Dickinson P, (2010) Crustacean neuropeptides. Cell Mol Life Sci 67: 4135-4169.
18. Christie AE, McCoole MD, Harmon SM, Baer KN, Lenz PH (2011) Genomic analyses of the Daphnia pulex peptidome. Gen Comp Endocrinol.
19. Christie AE, Nolan DH, Ohno P, Hartline N, Lenz PH, (2010) Identification of chelicerate neuropeptides using bioinformatics of publicly accessible expressed sequence tags. Gen Comp Endocrinol 170: 144-155.
20. Li B, Predel R, Neupert S, Hauser F, Tanaka Y, et al. (2008) Genomics, transcriptomics, and peptidomics of neuropeptides and protein hormones in the red flour beetle Tribolium castaneum. Genome Res 18: 113-122.
21. Amare A, Sweedler JV, (2007) Neuropeptide precursors in Tribolium castaneum. Peptides 28: 1282-1291.
22. Parmentier C, Hameury E, Dubessy C, Quan FB, Habert D, et al. (2011) Occurrence of two distinct urotensin II-related peptides in zebrafish provides new insight into the evolutionary history of the urotensin II gene family. Endocrinology 152: 2330-2341.
23. Dschietzig T, Bartsch C, Pregla R, Zurbrugg HR, Armbruster FP, et al. (2002) Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure. Regul Pept 110: 33-38.
24. Ross B, McKendy K, Giaid A, (2010) Role of urotensin II in health and disease. Am J Physiol Regul Integr Comp Physiol 298: R1156-1172.
25. McDonald J, Batuwangala M, Lambert DG, (2007) Role of urotensin II and its receptor in health and disease. J Anesth 21: 378-389.
26. Ong KL, Lam KS, Cheung BM, (2005) Urotensin II: its function in health and its role in disease. Cardiovasc Drugs Ther 19: 65-75.
27. Gartlon J, Parker F, Harrison DC, Douglas SA, Ashmeade TE, et al. (2001) Central effects of urotensin-II following ICV administration in rats. Psychopharmacology (Berl) 155: 426-433.
28. do Rego J-C, Leprince J, Scalbert E, Vaudry H, Costentin J, (2008) Behavioral actions of urotensin-II. Peptides 29: 838-844.
29. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, et al. (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401: 282-286.
30. Liu Q, Pong S-S, Zeng Z, Zhang Q, Howard AD, et al. (1999) Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 266: 174-178.
31. Jegou S, Cartier D, Dubessy C, Gonzalez BJ, Chatenet D, et al. (2006) Localization of the urotensin II receptor in the rat central nervous system. J Comp Neurol 495: 21-36.
32. Desai N, Sajjad J, Frishman WH, (2008) Urotensin II: a new pharmacologic target in the treatment of cardiovascular disease. Cardiol Rev 16: 142-153.
33. Douglas SA, Dhanak D, Johns DG, (2004) From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function. Trends Pharmacol Sci 25: 76-85.
34. Dun SL, Brailoiu GC, Yang J, Chang JK, Dun NJ, (2001) Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. Neurosci Lett 305: 9-12.
35. O'Shea M, Schaffer M, (1985) Neuropeptide function: the invertebrate contribution. Annu Rev Neurosci 8: 171-198.
36. Nusbaum MP, Blitz DM, (2012) Neuropeptide modulation of microcircuits. Curr Opin Neurobiol. 22: 592-601.
37. Kandel ER, (2001) The molecular biology of memory storage: a dialog between genes and synapses. Biosci Rep 21: 565-611.
38. Furukawa Y, Nakamaru K, Wakayama H, Fujisawa Y, Minakata H, et al. (2001) The enterins: a novel family of neuropeptides isolated from the enteric nervous system and CNS of Aplysia. J Neurosci 21: 8247-8261.
39. Sweedler JV, Li L, Rubakhin SS, Alexeeva V, Dembrow NC, et al. (2002) Identification and characterization of the feeding circuit-activating peptides, a novel neuropeptide family of Aplysia. J Neurosci 22: 7797-7808.
40. Jing J, Vilim FS, Horn CC, Alexeeva V, Hatcher NG, et al. (2007) From hunger to satiety: reconfiguration of a feeding network by Aplysia neuropeptide Y. J Neurosci. 27: 3490-3502.
41. Floyd PD, Li L, Rubakhin SS, Sweedler JV, Horn CC, et al. (1999) Insulin prohormone processing, distribution, and relation to metabolism in Aplysia californica. J Neurosci 19: 7732-7741.
42. Li L, Floyd PD, Rubakhin SS, Romanova EV, Jing J, et al. (2001) Cerebrin prohormone processing, distribution and action in Aplysia californica. J Neurochem 77: 1569-1580.
43. Jing J, Sweedler JV, Cropper EC, Alexeeva V, Park JH, et al. (2010) Feedforward compensation mediated by the central and peripheral actions of a single neuropeptide discovered using representational difference analysis. J Neurosci 30: 16545-16558.
44. Samarova EI, Bravarenko NI, Korshunova TA, Gulyaeva NV, Palotas A, et al. (2005) Effect of beta-amyloid peptide on behavior and synaptic plasticity in terrestrial snail. Brain Res Bull 67: 40-45.
45. Shemesh OA, Spira ME, (2010) Hallmark cellular pathology of Alzheimer's disease induced by mutant human tau expression in cultured Aplysia neurons. Acta Neuropathol 120: 209-222.
46. Walters ET, Moroz LL, (2009) Molluscan memory of injury: evolutionary insights into chronic pain and neurological disorders. Brain Behav Evol 74: 206-218.
47. Yampolsky L, Bouzinier M, (2010) Evolutionary patterns of amino acid substitutions in 12 Drosophila genomes. BMC Genomics 11: S10.
48. Lipinski KJ, Farslow JC, Fitzpatrick KA, Lynch M, Katju V, et al. (2011) High spontaneous rate of gene duplication in Caenorhabditis elegans. Curr Biol 21: 306-310.
49. Angerer RC, Davidson EH, Britten RJ, (1975) DNA sequence organization in the mollusc Aplysia californica. Cell 6: 29-39.
50. Fiedler TJ, Hudder A, McKay SJ, Shivkumar S, Capo TR, et al. (2010) The transcriptome of the early life history stages of the California Sea Hare Aplysia californica. Comp Biochem Physiol Part D Genomics Proteomics 5: 165-170.
51. Lasek RJ, Dower WJ, (1971) Aplysia californica: analysis of nuclear DNA in individual nuclei of giant neurons. Science 172: 278-280.
52. Moroz LL, Edwards JR, Puthanveettil SV, Kohn AB, Ha T, et al. (2006) Neuronal transcriptome of Aplysia: neuronal compartments and circuitry. Cell 127: 1453-1467.
53. Heyland A, Vue Z, Voolstra CR, Medina M, Moroz LL, (2011) Developmental transcriptome of Aplysia californica. J Exp Zool B Mol Dev Evol 316B: 113-134.
54. Bendtsen JD, Nielsen H, von Heijne G, Brunak S, (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340: 783-795.
55. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
56. Saitou N, Nei M, (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
57. Conlon JM, Tostivint H, Vaudry H, (1997) Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives. Regul Pept 69: 95-103.
58. Pi C, Liu J, Peng C, Liu Y, Jiang X, et al. (2006) Diversity and evolution of conotoxins based on gene expression profiling of Conus litteratus. Genomics 88: 809-819.
59. Miller MW, Rosen SC, Schissel SL, Cropper EC, Kupfermann I, et al. (1994) A population of SCP-containing neurons in the buccal ganglion of Aplysia are radula mechanoafferents and receive excitation of central origin. J Neurosci 14: 7008-7023.
60. Vilim FS, Sasaki K, Rybak J, Alexeeva V, Cropper EC, et al. (2010) Distinct mechanisms produce functionally complementary actions of neuropeptides that are structurally related but derived from different precursors. J Neurosci 30: 131-147.
61. Southey BR, Amare A, Zimmerman TA, Rodriguez-Zas SL, Sweedler JV, (2006) NeuroPred: a tool to predict cleavage sites in neuropeptide precursors and provide the masses of the resulting peptides. Nucleic Acids Res 34: W267-W272.
62. Ono JK, McCaman RE, (1992) In situ hybridization of whole-mounts of Aplysia ganglia using non-radioactive probes. J Neurosci Methods 44: 71-79.
63. Schaefer M, Picciotto MR, Kreiner T, Kaldany R-R, Taussig R, et al. (1985) Aplysia neurons express a gene encoding multiple FMRFamide neuropeptides. Cell 41: 457-467.
64. Lloyd PE, Mahon AC, Kupfermann I, Cohen JL, Scheller RH, et al. (1985) Biochemical and immunocytological localization of molluscan small cardioactive peptides in the nervous system of Aplysia californica. J Neurosci 5: 1851-1861.
65. Walters ET, Bodnarova M, Billy AJ, Dulin MF, Diaz-Rios M, et al. (2004) Somatotopic organization and functional properties of mechanosensory neurons expressing sensorin-A mRNA in Aplysia californica. J Comp Neurol 471: 219-240.
66. Gonzalez GC, Martinez-Padron M, Lederis K, Lukowiak K, (1992) Distribution and coexistence of urotensin I and urotensin II peptides in the cerebral ganglia of Aplysia californica. Peptides 13: 695-703.
67. Furukawa Y, Nakamaru K, Sasaki K, Fujisawa Y, Minakata H, et al. (2003) PRQFVamide, a novel pentapeptide identified from the CNS and gut of Aplysia. J Neurophysiol 89: 3114-3127.
68. Jing J, Weiss KR, (2001) Neural mechanisms of motor program switching in Aplysia. J Neurosci 21: 7349-7362.
69. Morgan PT, Jing J, Vilim FS, Weiss KR, (2002) Interneuronal and peptidergic control of motor pattern switching in Aplysia. J Neurophysiol 87: 49-61.
70. Proekt A, Vilim FS, Alexeeva V, Brezina V, Friedman A, et al. (2005) Identification of a new neuropeptide precursor reveals a novel source of extrinsic modulation in the feeding system of Aplysia. J Neurosci 25: 9637-9648.
71. Friedman AK, Weiss KR, (2010) Repetition priming of motoneuronal activity in a small motor network: intercellular and intracellular signaling. J Neurosci 30: 8906-8919.
72. Hurwitz I, Kupfermann I, Susswein AJ, (1997) Different roles of neurons B63 and B34 that are active during the protraction phase of buccal motor programs in Aplysia californica. J Neurophysiol 78: 1305-1319.
73. Susswein AJ, Byrne JH, (1988) Identification and characterization of neurons initiating patterned neural activity in the buccal ganglia of Aplysia. J Neurosci 8: 2049-2061.
74. Mousley A, Maule AG, Halton DW, Marks NJ, (2005) Inter-phyla studies on neuropeptides: the potential for broad-spectrum anthelmintic and/or endectocide discovery. Parasitology 131: S143-S167.
75. Rajpara SM, Garcia PD, Roberts R, Eliassen JC, Owens DF, et al. (1992) Identification and molecular cloning of a neuropeptide Y homolog that produces prolonged inhibition in Aplysia neurons. Neuron 9: 505-513.
76. Hoek RM, van Kesteren RE, Smit AB, de Jong-Brink M, Geraerts WP, (1997) Altered gene expression in the host brain caused by a trematode parasite: neuropeptide genes are preferentially affected during parasitosis. Proc Natl Acad Sci U S A 94: 14072-14076.
77. Soloviev M, Takahashi T, Fujisawa T (2010) Peptidomic approaches to the identification and characterization of functional peptides in Hydra. Peptidomics: Humana Press. 275-292.
78. Harrison LM, Kastin AJ, Weber JT, Banks WA, Hurley DL, et al. (1994) The opiate system in invertebrates. Peptides 15: 1309-1329.
79. Lovejoy DA, (2009) Structural evolution of urotensin-I: reflections of life before corticotropin releasing factor. Gen Comp Endocrinol 164: 15-19.
80. Waugh D, Youson J, Mims SD, Sower S, Conlon JM, (1995) Urotensin II from the river lamprey (Lampetra fluviatilis), the sea lamprey (Petromyzon marinus), and the paddlefish (Polyodon spathula). Gen Comp Endocrinol 99: 323-332.
81. Conlon JM, O'Harte F, Smith DD, Balment RJ, Hazon N, (1992) Purification and characterization of urotensin II and parvalbumin from an elasmobranch fish, Scyliorhinus canicula (common dogfish). Neuroendocrinology 55: 230-235.
82. Waugh D, Conlon JM, (1993) Purification and characterization of urotensin II from the brain of a teleost (trout, Oncorhynchus mykiss) and an elasmobranch (skate, Raja rhina). Gen Comp Endocrinol 92: 419-427.
83. Vilim FS, Sasaki K, Alexeeva V, Romanova EV, Richmond TA, et al. (2007) Identification and characterization of a urotensin II-like peptide in the feeding circuitry of Aplysia. Society for Neuroscience. San Diego, CA: Neuroscience Meeting Planner, program 288.9.
84. Conlon JM, Arnold-Reed D, Balment RJ, (1990) Post-translational processing of prepro-urotensin II. FEBS Lett 266: 37-40.
85. Chartrel N, Leprince J, Dujardin C, Chatenet D, Tollemer H, et al. (2004) Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord. J Neurochem 91: 110-118.
86. Yui R, Iwanaga T, Kuramoto H, Fujita T, (1985) Neuropeptide immunocytochemistry in protostomian invertebrates, with special reference to insects and molluscs. Peptides 6: 411-415.
87. Gonzalez GC, Martinez-Padron M, Ko D, Lukowiak K, Lederis K, (1991) Urotensin I-like immunoreactivity in the central nervous system of Aplysia californica. Peptides 12: 787-793.
88. Gonzalez GC, Roger I, Gonzalez E, Martinez-Padron M, Moore GJ, et al. (1995) Angiotensinogen-like epitopes are present in the CNS of Aplysia california and co-localize with urotensin I- and urotensin II-like immunoreactivities in the cerebral ganglia. Neuroreport 6: 541-544.
89. Sawada M, Ichinose M, (1999) Potentiation of GABA(A) receptor-mediated Cl-current by urotensin peptides in identified Aplysia neurons. J Neurosci Res 56: 547-552.
90. Lovejoy DA, Balment RJ, (1999) Evolution and Physiology of the Corticotropin-Releasing Factor (CRF) Family of Neuropeptides in Vertebrates. Gen Comp Endocrinol 115: 1-22.
91. Tostivint H, Joly L, Lihrmann I, Parmentier C, Lebon A, et al. (2006) Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families. Proc Natl Acad Sci U S A 103: 2237-2242.
92. Tostivint H, Lihrmann I, Vaudry H, (2008) New insight into the molecular evolution of the somatostatin family. Mol Cell Endocrinol 286: 5-17.
93. LeRoith D, Pickens W, Crosby LK, Berelowitz M, Holtgrefe M, et al. (1985) Evidence for multiple molecular weight forms of somatostatin-like material in Escherichia coli. Biochim Biophys Acta 838: 335-342.
94. LeRoith D, Pickens W, Wilson GL, Miller B, Berelowitz M, et al. (1985) Somatostatin-like material is present in flowering plants. Endocrinology 117: 2093-2097.
95. Craig AG, Norberg T, Griffin D, Hoeger C, Akhtar M, et al. (1999) Contulakin-G, an O-glycosylated invertebrate neurotensin. J Biol Chem 274: 13752-13759.
96. Hunt BD, Ng LL, Lambert DG, (2010) A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects. Naunyn Schmiedebergs Arch Pharmacol 382: 1-31.
97. Do-Rego JC, Chatenet D, Orta MH, Naudin B, Le Cudennec C, et al. (2005) Behavioral effects of urotensin-II centrally administered in mice. Psychopharmacology (Berl) 183: 103-117.
98. Wu JS, Vilim FS, Hatcher NG, Due MR, Sweedler JV, et al. (2010) Composite modulatory feedforward loop contributes to the establishment of a network state. J Neurophysiol 103: 2174-2184.
99. Fiore L, Meunier J-M, (1975) A network of synaptic relations in the buccal ganglia of Aplysia. Brain Res 92: 336-340.
100. Jahan-Parwar B, Fredman SM, (1976) Cerebral ganglion of Aplysia: cellular organization and origin of nerves. Comp Biochem Physiol A Comp Physiol 54: 347-357.
101. Lisitsyn N, Lisitsyn N, Wigler M, (1993) Cloning the differences between two complex genomes Science. 259: 946-951.
102. Hubank M, Schatz DG, (1994) Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22: 5640-5648.
103. Vilim FS, Alexeeva V, Moroz LL, Li L, Moroz TP, et al. (2001) Cloning, expression and processing of the CP2 neuropeptide precursor of Aplysia. Peptides 22: 2027-2038.
104. Sive HL, St John T, (1988) A simple subtractive hybridization technique employing photoactivatable biotin and phenol extraction. Nucleic Acids Res 16: 10937.
105. Sasaki K, Brezina V, Weiss KR, Jing J, (2009) Distinct inhibitory neurons exert temporally specific control over activity of a motoneuron receiving concurrent excitation and inhibition. J Neurosci 29: 11732-11744.